Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II–receptor blockers for ischemic heart disease
WL Baker, CI Coleman, J Kluger… - Annals of internal …, 2009 - acpjournals.org
Background: Patients with ischemic heart disease and preserved ventricular function
experience considerable morbidity and mortality despite standard medical therapy. Purpose …
experience considerable morbidity and mortality despite standard medical therapy. Purpose …
[PDF][PDF] Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II–Receptor Blockers for Ischemic Heart Disease
Ann Intern Med, 2009 - academia.edu
Background: Patients with ischemic heart disease and preserved ventricular function
experience considerable morbidity and mortality despite standard medical therapy. Purpose …
experience considerable morbidity and mortality despite standard medical therapy. Purpose …
[HTML][HTML] Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease
WL Baker, CI Coleman, J Kluger… - Database of Abstracts …, 2009 - ncbi.nlm.nih.gov
The authors concluded that ACE inhibitors can improve rates of mortality and myocardial
infarctions in patients with stable ischaemic heart disease and preserve left ventricular …
infarctions in patients with stable ischaemic heart disease and preserve left ventricular …
[PDF][PDF] Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II–Receptor Blockers for Ischemic Heart Disease
Ann Intern Med, 2009 - researchgate.net
Background: Patients with ischemic heart disease and preserved ventricular function
experience considerable morbidity and mortality despite standard medical therapy. Purpose …
experience considerable morbidity and mortality despite standard medical therapy. Purpose …
Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease.
WL Baker, CI Coleman, J Kluger… - Annals of Internal …, 2009 - europepmc.org
Background Patients with ischemic heart disease and preserved ventricular function
experience considerable morbidity and mortality despite standard medical therapy. Purpose …
experience considerable morbidity and mortality despite standard medical therapy. Purpose …
[PDF][PDF] Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II–Receptor Blockers for Ischemic Heart Disease
Ann Intern Med, 2009 - Citeseer
Background: Patients with ischemic heart disease and preserved ventricular function
experience considerable morbidity and mortality despite standard medical therapy. Purpose …
experience considerable morbidity and mortality despite standard medical therapy. Purpose …
[PDF][PDF] Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II–Receptor Blockers for Ischemic Heart Disease
Ann Intern Med, 2009 - nnt.pharm.su.ac.th
Background: Patients with ischemic heart disease and preserved ventricular function
experience considerable morbidity and mortality despite standard medical therapy. Purpose …
experience considerable morbidity and mortality despite standard medical therapy. Purpose …
[引用][C] Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II–Receptor Blockers for Ischemic Heart Disease
WL Baker - Annals of Internal Medicine, 2009 - cir.nii.ac.jp
Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors
or Angiotensin II–Receptor Blockers for Ischemic Heart Disease | CiNii Research CiNii 国立 …
or Angiotensin II–Receptor Blockers for Ischemic Heart Disease | CiNii Research CiNii 国立 …
Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease
WL Baker, CI Coleman, J Kluger… - Annals of internal …, 2009 - pubmed.ncbi.nlm.nih.gov
Background Patients with ischemic heart disease and preserved ventricular function
experience considerable morbidity and mortality despite standard medical therapy. Purpose …
experience considerable morbidity and mortality despite standard medical therapy. Purpose …
[PDF][PDF] Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II–Receptor Blockers for Ischemic Heart Disease
Ann Intern Med, 2009 - academia.edu
Background: Patients with ischemic heart disease and preserved ventricular function
experience considerable morbidity and mortality despite standard medical therapy. Purpose …
experience considerable morbidity and mortality despite standard medical therapy. Purpose …